Medinvest - Company finances
|
EUR
|
2021
From: 2021-08-23
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 600 | 20,648 | 95,303 | 90,419 | 82,459 |
| Profit before tax | - | - | - | 205,400 | 1,036,999 |
| Net profit | -26,523 | -30,881 | 103,104 | 174,587 | 873,646 |
| Equity | -24,023 | -54,905 | 48,200 | 222,786 | 1,096,432 |
| Liabilities | 785,896 | 1,145,223 | 1,935,783 | 2,733,459 | 898,628 |
| Non-current assets | 514,772 | 506,308 | 474,966 | 2,470,263 | 545,766 |
| Current assets | 246,910 | 583,966 | 1,508,969 | 485,930 | 1,449,294 |
| Total assets | 761,682 | 1,090,274 | 1,983,935 | 2,956,193 | 1,995,060 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 13,557 | 15,440 | 143,068 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | +3341.3% | +361.6% | -5.1% | -8.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -3.5% | -2.8% | 5.2% | 5.9% | 43.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | 213.9% | 78.4% | 79.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -4420.5% | -149.6% | 108.2% | 193.1% | 1059.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | 227.2% | 1257.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 40.2 | 12.3 | 0.8 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 600 | 20,648 | 95,303 | 90,419 | 82,459 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medinvest - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-09-16 | 2025-09-18 | 0.44 |
| 2022-02-17 | 2022-02-27 | 4.41 |
| 2022-01-31 | 2022-02-16 | 3.34 |
| 2022-01-18 | 2022-01-30 | 2.85 |
| 2021-12-16 | 2022-01-17 | 1.90 |
| 2021-11-16 | 2021-12-15 | 0.95 |
| 2021-10-18 | 2021-10-27 | 117.08 |
Medinvest - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Medinvest is: 545 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-30 | 2026-09-02 | 545.18 |
| 2026-08-25 | 2026-08-29 | 116713.95 |
| 2026-08-23 | 2026-08-24 | 118711.93 |
| 2026-08-19 | 2026-08-22 | 121281.72 |
| 2026-08-14 | 2026-08-18 | 121730.3 |
| 2026-08-13 | 2026-08-13 | 126194.56 |
| 2026-08-12 | 2026-08-12 | 127027.73 |
| 2026-08-07 | 2026-08-11 | 127718.32 |
| 2026-07-24 | 2026-08-06 | 151422.33 |
| 2026-06-22 | 2026-07-23 | 150709.55 |
| 2025-12-30 | 2026-01-24 | 1.85 |
| 2025-12-18 | 2025-12-29 | 2.12 |
| 2025-09-19 | 2025-09-25 | 0.84 |
| 2025-09-02 | 2025-09-14 | 0.84 |
| 2025-09-01 | 2025-09-01 | 450.72 |
| 2025-08-28 | 2025-08-31 | 450.12 |
| 2025-01-01 | 2025-01-28 | 1.2 |
| 2024-12-30 | 2024-12-30 | 1480.0 |
| 2024-10-16 | 2024-10-16 | 4.52 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medinvest, UAB (code 305879587) is a Private Limited Liability Company engaged in rental and operating of own or leased real estate. In the latest financial year, 2025, the company generated revenue of €82.5K and net profit of €873.6K, showing a sharp profit result relative to turnover. Revenue declined by 8.8% year on year and by 13.5% over two years, from €95.3K in 2023 to €90.4K in 2024 and €82.5K in 2025. Over the same period, profitability strengthened materially: net profit increased from €103.1K in 2023 to €174.6K in 2024 and then to €873.6K in 2025. Total assets stood at €2.00M at year-end 2025, supported by equity of €1.10M and liabilities of €898.6K. The equity ratio was 55.0%, debt-to-equity was 0.82, ROE reached 79.7%, and ROA was 43.8%. Asset turnover remained low at 0.04x, reflecting limited revenue generation against the asset base. Revenue per employee was €82.5K, while profit per employee reached €873.6K.